About Putative deaminase APOBEC-4
Putative deaminase APOBEC-4 (APOBEC4) is a protein
from Homo sapiens identified by UniProt accession
Q8WW27, 367 residues long.
MolForge cross-references it against 0 known binders and
16 disease associations.
Target properties
| Protein name | Putative deaminase APOBEC-4 |
| UniProt accession | Q8WW27 |
| Gene | APOBEC4 |
| Organism | Homo sapiens |
| Length | 367 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (16)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.35
- aspartate aminotransferase measurement · score 0.11
- aspartate aminotransferase to alanine aminotransferase ratio · score 0.07
- chronotype measurement · score 0.04
- type 1 diabetes mellitus · score 0.04
- systemic lupus erythematosus · score 0.02
- squamous cell carcinoma · score 0.01
- lung adenocarcinoma · score 0.01
- myelodysplastic syndrome · score 0.00
- endometrial carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WW27-F1 | alphafold | PREDICTED | 71.44 | — |
Amino-acid sequence (367 residues)
MEPIYEEYLA NHGTIVKPYY WLSFSLDCSN CPYHIRTGEE ARVSLTEFCQ IFGFPYGTTF PQTKHLTFYE LKTSSGSLVQ KGHASSCTGN YIHPESMLFE MNGYLDSAIY NNDSIRHIIL YSNNSPCNEA NHCCISKMYN FLITYPGITL SIYFSQLYHT EMDFPASAWN REALRSLASL WPRVVLSPIS GGIWHSVLHS FISGVSGSHV FQPILTGRAL ADRHNAYEIN AITGVKPYFT DVLLQTKRNP NTKAQEALES YPLNNAFPGQ FFQMPSGQLQ PNLPPDLRAP VVFVLVPLRD LPPMHMGQNP NKPRNIVRHL NMPQMSFQET KDLGRLPTGR SVEIVEITEQ FASSKEADEK KKKKGKK
Explore Putative deaminase APOBEC-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets